Abstract:Microwave ablation plus α programmed death ligand 1 therapy may mediate the polarization of tumor‐associated macrophages (TAM1s) in the tumor microenvironment, thereby slowing down tumor growth, which are at least partially related to the nuclear factor‐κB/JAK‐STAT1 signaling pathway. Furthermore, blocking the γ‐interferon‐Cxcl9‐CD8+ T axis promoted tumor progression and discovered a potential involvement of IRF8‐regulated TAMs in preventing T cell exhaustion. Although microwave ablation (MWA) is an important curative therapy in colorectal cancer liver metastasis, recurrence still occurs clinically. Our previous studies have shown that the expression of programmed cell death 1 ligand 1 (PD‐L1) is upregulated following MWA, suggesting that MWA combined with anti‐PD‐L1 treatment can serve as a promising clinical therapeutic strategy against cancer. Using MWA‐treated preclinical mice models, MWA combined with αPD‐L1 treatment decreased tumor growth and prolonged overall survival (OS). Furthermore, through flow cytometry and single‐cell RNA sequencing analysis, we determined that the MWA plus αPD‐L1 therapy significantly suppressed CD8+ T cell exhaustion and enhanced their effector function. A significant increase in γ‐interferon (IFN‐γ) stimulated transcription factors, specifically Irf8, was observed. This enhancement facilitated the polarization of tumor‐associated macrophages (TAM1s and TAM2s) through the nuclear factor‐κB/JAK‐STAT1 signaling pathway. Furthermore, the combination therapy stimulated the production of CXC motif chemokine ligand (CXCL9) by TAM1s and tumor cells, potentially increasing the chemotaxis of CD8 T cells and Th1 cells. Knocking out Cxcl9 in MC38 tumor cells or using CXCL9 blockade enhanced tumor growth of untreated tumors and shortened OS. Taken together, our study showed that blocking the IFN‐γ‐Cxcl9‐CD8+ T axis promoted tumor progression and discovered a potential involvement of IRF8‐regulated TAMs in preventing T cell exhaustion. Collectively, we identified that the combination of MWA with anti‐PD‐L1 treatment holds promise as a therapeutic strategy to rejuvenate the immune response against tumors. This merits further exploration in clinical studies.

Immunomodulatory effects of microwave ablation on malignant tumors

Microwave ablation enhances the systemic immune response in patients with lung cancer

Distinct immunoreactions after a primary tumor microwave ablation using different heating parameters in a VX2 tumor model

Distinct Immunoreactions after Microwave Ablation of Primary Tumor with Different Heating Parameters in VX2 Tumor Model

Microwave ablation induces abscopal effect via enhanced systemic antitumor immunity in colorectal cancer

Microwave ablation induces Th1-type immune response with activation of ICOS pathway in early-stage breast cancer

H 2 S-Reactivating Antitumor Immune Response after Microwave Thermal Therapy for Long-Term Tumor Suppression

[Current Status and Progress of Thermal Ablation Combined with Immunotherapy for Lung Tumors]

Progress in the cryoablation and cryoimmunotherapy for tumor

Enhanced abscopal anti-tumor response via a triple combination of thermal ablation, IL-21, and PD-1 inhibition therapy

Immunomodulatory effects of ablation therapy on tumors: Potentials for combination with immunotherapy

Inducing the Abscopal Effect in Liver Cancer Treatment: The Impact of Microwave Ablation Power Levels and PD-1 Antibody Therapy

Immune abscopal effect of microwave ablation for lung metastases of endometrial carcinoma

Glycolysis inhibition induces anti-tumor central memory CD8 + T cell differentiation upon combination with microwave ablation therapy

Landscape of the Peripheral Immune Response Induced by Local Microwave Ablation in Patients with Breast Cancer.

SPACES: Our Team's Experience in Lung Tumor Microwave Ablation

Clinical application status and prospect of the combined anti-tumor strategy of ablation and immunotherapy

Tumor Thermal Ablation Enhancement by Micromaterials

Immunostimulatory effects of thermal ablation: Challenges and future prospects

Thermal-responsive activation of engineered bacteria to trigger antitumor immunity post microwave ablation therapy

Microwave ablation combined with PD‐L1 blockade synergistically promotes Cxcl9‐mediated antitumor immunity